6-CHLORO-8-METHYL-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE, 95.0%, 2g

5-chloro-3-(hydroxyimino)-2-oxoindoline-7-carboxylic acid, 50mg

2-Amino-4-(methylsulfonyl)benzoic acid, 95.0%, 5g

2-(TERT-BUTYLDIMETHYLSILYLOXY)ETHANAMINE, 95.0%, 100g

N,2-dimethyl-3-pyrrolidin-1-ylpropan-1-amine, 95.0%, 1g

GC capillary column ROTI®Cap-5, 50 m, 0.32 mm, 3.00 µm, 1 Piece(s)

hexahydro-2H-pyrazino[1,2-a]pyrazin-1(6H)-one, 95.0%, 1g

Odanacatib, 99.82%, 10mg

ATOVAQUONE, 95.0%, 250mg

(R)-6-bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide, 95%, 50mg

(S)-4,4'-Bis(diphenylphosphino)-2,2',6,6'-tetramethoxy-3,3'-bipyridine, 98%, 1g

3-methyl-2-(methylamino)-1-butanol, 95.0%, 250mg

4-Fluoroisoquinoline, 97.0%, 10g